Shopping Cart
- Remove All
- Your shopping cart is currently empty
DDO-2728 is a selective pyrazolopyrimidine ALKBH5 inhibitor with an IC50 of 2.97 μM. It enhances the level of N6-methyladenosine (m6A) modification in acute myeloid leukemia (AML) cells and exhibits antiproliferative activity in these cells. Additionally, it demonstrates antitumor efficacy in MV4-11 xenograft models.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | Inquiry | 10-14 weeks | |
50 mg | Inquiry | 10-14 weeks |
Description | DDO-2728 is a selective pyrazolopyrimidine ALKBH5 inhibitor with an IC50 of 2.97 μM. It enhances the level of N6-methyladenosine (m6A) modification in acute myeloid leukemia (AML) cells and exhibits antiproliferative activity in these cells. Additionally, it demonstrates antitumor efficacy in MV4-11 xenograft models. |
Molecular Weight | 578.452 |
Formula | C28H17F3N4O7 |
Cas No. | 3029515-97-4 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.